Record Sales and Profitability
Full year sales of $1.65 billion, up ~4.6% YoY, marking record sales and profitability for the third consecutive year; consolidated adjusted EBITDA of $367.6 million (22.3% of sales) and adjusted EPS of $6.19, up 19% YoY.
Strong Metal Coatings Performance
Metal Coatings segment sales increased 14.1% for the year and delivered strong EBITDA (over $235 million, ~31% of sales); Q4 Metal Coatings sales grew 25.7% YoY, driving Q4 consolidated sales of $385.1 million (up 9.4% YoY).
Improved Quarterly Profitability and Margins
Q4 gross profit $87.6 million (22.7% of sales, +30 bps YoY); Q4 operating income $57.1 million (14.8% of sales), a 330 bp improvement vs. prior year; Q4 adjusted EBITDA $81.3 million (21.1% of sales) up from $71.2 million.
Balance Sheet Strength and Debt Reduction
Reduced debt by $385 million during fiscal 2026 and ended the year with net debt-to-EBITDA of 1.4x, providing financial flexibility; Q4 interest expense improved by $6.2 million to $11.2 million due to debt paydown and favorable financing actions.
Washington, Missouri Facility Milestone
Completed greenfield aluminum coil precoat metals facility (total investment ~ $125 million over 3 years); facility was profitable at contribution margin in Q4, produced about $11 million revenue in FY26, and running at ~40% utilization with targeted output ~45–50k tons this year as volumes ramp.
Capital Allocation Discipline and Shareholder Returns
Invested $80.8 million in capital expenditures (growth-focused), acquired a galvanizing facility in Canton, OH for ~$30 million, paid $23 million in dividends and repurchased $20 million of stock at an average $98.28 per share.
Strong Cash Flows from JV and Operating Cash
Reported cash flows from operations of $525 million in 2026, which included substantial cash distributions from the AVAIL joint venture (net distributions cited ~$273M); AVAIL equity earnings for the year totaled $210 million (driven by divestitures within the JV).
Guidance and Growth Visibility for FY2027
Reiterated FY2027 guidance: sales $1.725–1.775 billion, adjusted EBITDA $360–400 million, adjusted diluted EPS $6.50–7.00, and planned debt reduction of $130–170 million, indicating management confidence in continued growth.